Skip to content

Prediction and evaluation model of neoadjuvant therapy for esophageal cancer based on multimodal imaging

Prediction and evaluation model of neoadjuvant therapy for esophageal cancer based on multimodal imaging

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072054
Enrollment
Unknown
Registered
2023-06-01
Start date
2022-01-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Sponsors

Sun Yat-Sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Collect esophageal cancer patients from 2012 to 2023. The gold standard for diagnosis is esophageal cancer confirmed by preoperative biopsy or postoperative pathological results; 2. Have received dual-energy CT and MRI of the esophagus at baseline and can obtain original images of dual-energy CT and MRI (DICOM format); 3. Surgery should be performed 6-8 weeks after neoadjuvant therapy for esophageal cancer, and dual-energy CT and MRI of esophageal cancer should be performed before surgery, and dual-energy CT and MRI images can be obtained; 4. Receive neoadjuvant therapy and radical surgery for esophageal cancer; 5. No distant metastasis of esophageal cancer;

Exclusion criteria

Exclusion criteria: 1. Receive palliative care; 2. The original images of dual-energy CT and MRI of esophageal cancer do not meet the standard; 3. The tumor has been treated by dual-energy CT and MRI at the initial diagnosis; 4. The patient suffers from other cancers at the same time; 5. Incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Evaluation of curative effect;Objective response rate;

Secondary

MeasureTime frame
Overall Survival;Progression-Free Survival;

Countries

China

Contacts

Public ContactLizhi Liu

Sun Yat-Sen University Cancer Center

liulizh@sysucc.org.cn+86 136 6052 8375

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026